New Zealand markets closed

Regeneron Pharmaceuticals, Inc. (REGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
985.02+4.45 (+0.45%)
At close: 04:00PM EDT
985.02 0.00 (0.00%)
After hours: 04:34PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close980.57
Open984.04
Bid984.01 x 100
Ask985.68 x 200
Day's range983.16 - 995.41
52-week range684.81 - 998.33
Volume259,279
Avg. volume442,674
Market cap108.535B
Beta (5Y monthly)0.17
PE ratio (TTM)29.07
EPS (TTM)33.88
Earnings date01 Aug 2024 - 05 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est1,060.68
  • Insider Monkey

    The Biggest Biotechnology Company in Europe

    We’ve recently covered a list of 20 Biggest Publicly-Traded Biotech Companies based on market caps that you can visit here. Biotechnology and Industry 2023: Market Growth, Transformations, and Technological Milestones The global biotechnology market was valued at approximately $1.55 trillion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 13.96% from 2024 to 2030, reaching a staggering $3.88 trillion by 2030. The […]

  • Insider Monkey

    The Biggest Publicly Traded Biotech Company

    In this article, we will be discussing the biggest publicly traded biotech company that ranks at the top of our free list of the 20 Biggest Publicly Traded Biotech Companies. Biotechnology and Industry 2023: Market Growth, Transformations, and Technological Milestones The global biotechnology market was valued at approximately $1.55 trillion in 2023 and is projected to grow at a compound annual growth rate […]

  • Zacks

    Regeneron (REGN) Announces Positive Data on Oncology Candidate

    Regeneron's (REGN) REGN7075, in combination with its oncology drug Libtayo, generates anti-tumor responses in patients with microsatellite-stable colorectal cancer.